Non-specificity and synergy at the binding site of the carboplatin-induced DNA adduct via molecular dynamics simulations of the MutSα–DNA recognition complex

References

• Andrews, P., & Howell, S. (1990). Cellular pharmacology of cisplatin: Perspectives on mechanisms of acquired resistance. Cancer Cells, 2, 35–43.
   PubMed Web of Science ®Google Scholar
• Auffinger, P., & Westhof, E. (1997). Three ns of multiple molecular dynamics simulations of solvated tRNA(ASP) anticodon hairpin. Journal of Molecular Biology, 269, 326–341.
   PubMed Web of Science ®Google Scholar
• Barlow, D. J., & Thornton, J. M. (1983). Ion-pairs in proteins. Journal of Molecular Biology, 168, 867–885.
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A., & Haak, J. R. (1984). Molecular dynamics with coupling to an external bath. Journal of Chemical Physics, 81, 3684–3690.
   Web of Science ®Google Scholar
• Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., Swaminatan, S., & Karplus, M. (1983). CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. Journal of Computational Chemistry, 4, 187–217.
   Web of Science ®Google Scholar
• Cannavo, E., Gerrits, B., Marra, G., Schlapbach, R., & Jiricny, J. (2007). Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. Journal of Biological Chemistry, 282, 2976–2986.
   PubMed Web of Science ®Google Scholar
• Caves, L. S. D., Evanseck, J. D., & Karplus, M. (1998). Locally accessible conformations of proteins: Multiple molecular dynamics simulations of crambin. Protein Science, 7, 649–666.
   PubMed Web of Science ®Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle Mesh Ewald: An N Log(N) method for Ewald sums in large systems. Journal of Chemical Physics, 98, 10089–10092.
   Web of Science ®Google Scholar
• Deans, A. J., & West, S. C. (2011). DNA interstrand crosslink repair and cancer. Nature Reviews, 11, 467–480.
   Web of Science ®Google Scholar
• Desiraju, G. R., & Steiner, T. (1999). The weak hydrogen bond in structural chemistry and biology. New York, NY: Oxford University Press.
   Google Scholar
• Drotschmann, K., Topping, R. P., Clodfelter, J. E., & Salsbury, F. R., Jr (2004). Mutations in the nucleotide-binding domain of MutS homologs uncouple cell death from cell survival. DNA Repair (Amsterdam), 3, 729–742.
   PubMed Web of Science ®Google Scholar
• Duckett, D. R., Drummond, J. T., Alastair, I. H., Murchie, A. I. H., Reardon, J. T., Joyce, T., … Modrich, P. (1996). Human MutSα recognizes damaged DNA base pairs containing 06-methylguanine, 04-methylthymine, or the cisplatin-d(GpG) adduct. Proceedings of the National Academy of Sciences USA, 93, 6443–6447.
   PubMed Web of Science ®Google Scholar
• Dutta, S. (2011). Studying the interaction of cancer and thrombosis therapeutics with protein and DNA (Doctoral dissertation). Wake Forest University, USA.
   Google Scholar
• Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998). Cluster analysis and display of genome-wide expression patterns. Proceedings of the National Academy of Sciences USA, 95, 14863–14868.
   PubMed Web of Science ®Google Scholar
• Elizondo-Riojas, M. A., & Kozelka, J. (2001). Unrestrained 5 ns molecular dynamics simulation of a cisplatin–DNA 1,2-GG adduct provides a rationale for the NMR features and reveals increased conformational flexibility at the platinum binding site. Journal of Molecular Biology, 314, 1227–1243.
   PubMed Web of Science ®Google Scholar
• Fink, D., Nebel, S., Aebi, S., Zheng, H., Cenni, B., Nehme, A., … Howell, S. B. (1996). The role of DNA mismatch repair in platinum drug resistance. Cancer Research, 56, 4881–4886.
   PubMed Web of Science ®Google Scholar
• Gelasco, A., & Lippard, S. J. (1998). NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(ii) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin. Biochemistry, 37, 9230–9239.
   PubMed Web of Science ®Google Scholar
• Ghosh, S., Salsbury, F. R., Jr, Horita, D. A., & Gmeiner, W. H. (2011). Zn2+ selectively stabilizes FdU-substituted DNA through a unique major groove binding motif. Nucleic Acids Research, 39, 4490–4498.
   PubMed Web of Science ®Google Scholar
• Ginsburg, G. S., & Willard, H. F. (2009). Genomic and personalized medicine: Foundations and applications. Translational Research, 154, 277–287.
   PubMed Web of Science ®Google Scholar
• Glusker, J. P. (1998). Directional aspects of intermolecular interactions. Berlin: Springer-Verlag.
   Google Scholar
• Harrap, K. R. (1985). Preclinical studies identifying carboplatin as a viable cisplatin alternative. Cancer Treatment Reviews, 12, 21–33.
   PubMed Web of Science ®Google Scholar
• Horita, D. A., Zhang, W., Smithgall, T. E., Gmeiner, W. H., & Byrd, R. A. (2000). Dynamics of the Hck-SH3 domain: Comparison of experiment with multiple molecular dynamics simulations. Protein Science, 9, 95–103.
   PubMed Web of Science ®Google Scholar
• Horowitz, S., & Trievel, R. C. (2012). Carbon–oxygen hydrogen bonding in biological structure and function. Journal of Biological Chemistry, 287, 41576–41582.
   PubMed Web of Science ®Google Scholar
• Huang, H., Dooley, P. A., Harris, C. M., Harris, T. M., & Stone, M. P. (2009). Differential base stacking interactions induced by trimethylene interstrand DNA cross-links in the 5′-CpG-3′ and 5′-GpC-3′ sequence contexts. Chemical Research in Toxicology, 22, 1810–1816.
   PubMed Web of Science ®Google Scholar
• Huang, J.-C., Zamble, D. B., Reardon, J. T., Lippard, S. J., & Sancar, A. (1994). HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease. Proceedings of the National Academy of Sciences USA, 91, 10394–10398.
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14, 33–38.
   PubMed Web of Science ®Google Scholar
• Hunenberger, P. H., Mark, A. E., & van Gunsteren, W. F. (1995). Fluctuation and cross-correlation analysis of protein motions observed in nanosecond molecular dynamics simulations. Journal of Molecular Biology, 252, 492–503.
   PubMed Web of Science ®Google Scholar
• Iyer, R. R., Pluciennik, A., Burdett, V., & Modrich, P. L. (2006). DNA mismatch repair: Functions and mechanisms. Chemical Reviews, 106, 302–323.
   PubMed Web of Science ®Google Scholar
• Jamieson, E. R., & Lippard, S. J. (1999). Structure, recognition, and processing of cisplatin–DNA adducts. Chemical Reviews, 99, 2467–2498.
   PubMed Web of Science ®Google Scholar
• Janin, J. (1999). Wet and dry interfaces: The role of solvent in protein–protein and protein–DNA recognition. Structure, 7, R277–R279.
   Google Scholar
• Jeffrey, G. A., & Saenger, W. (1991). Hydrogen bonding in biological structures. Heidelberg: Springer Verlag.
   Google Scholar
• Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulated liquid water. Journal of Chemical Physics, 79, 926–935.
   Web of Science ®Google Scholar
• Kale, L., Skeel, R., Bhandarkar, M., Brunner, R., Gursoy, A., Krawetz, N., … Schulten, K. (1999). NAMD2: Greater scalability for parallel molecular dynamics. Journal of Computational Physics, 15, 1283–1312.
   Google Scholar
• Kartalou, M., & Essigmann, J. M. (2001). Recognition of cisplatin adducts by cellular proteins. Mutation Research, 478, 1–21.
   PubMed Web of Science ®Google Scholar
• Kelland, L. (2007). The resurgence of platinum-based cancer chemotherapy. Nature, 7, 573–584.
   Web of Science ®Google Scholar
• Knaggs, M. H., Salsbury, F. R., Jr, Edgell, M. H., & Fetrow, J. S. (2007). Insights into correlated motions and long-range interactions in CheY derived from molecular dynamics simulations. Biophysical Journal, 15, 2062–2079.
   Google Scholar
• Kuman, S., & Nussinov, R. (2002). Close-range electrostatic interactions in proteins. ChemBioChem, 3, 604–617.
   PubMed Web of Science ®Google Scholar
• Kuzmanic, A., & Zagrovic, B. (2010). Determination of ensemble-average pairwise root mean-square deviation from experimental B-factors. Biophysical Journal, 98, 861–871.
   PubMed Web of Science ®Google Scholar
• Livesay, D. R., Huynh, D. H., Dallakyan, S., & Jacobs, D. J. (2008). Hydrogen bond networks determine emergent mechanical and thermodynamic properties across a protein family. Chemistry Central Journal, 2.
   PubMedGoogle Scholar
• Loccisano, A. E., Acevedo, O., DeChancie, J., Schulze, B. G., & Evanseck, J. D. (2004). Enhanced sampling by multiple molecular dynamics trajectories: Carbonmonoxy myoglobin 10 micros A0–>A(1–3 transition from ten 400 picosecond simulations. Journal of Molecular Graphics and Modelling, 22, 369–376.
   PubMed Web of Science ®Google Scholar
• MacKerell, A. D., Jr, Banavali, N., & Foloppe, N. (2001). Development and current status of the CHARMM force field for nucleic acids. Biopolymers, 56, 257–265.
   Web of Science ®Google Scholar
• MacKerell, A. D., Jr, Bashford, D., Bellot, M., Dunbrack, R. L., Evanseck, J. D., Field, M. J., … Karplus, M. (1998). All-atom empirical potential for molecular modeling and studies of proteins. Journal of Physical Chemistry B, 102, 3586–3616.
   PubMed Web of Science ®Google Scholar
• Marzilli, G. L., Saad, J. S., Kuklenyik, Z., Keating, K. A., & Xu, Y. (2001). Relationship of solution and protein-bound structures of DNA duplexes with the major intrastrand cross-link lesions formed on cisplatin binding to DNA. Journal of the American Chemical Society, 123, 2764–2770.
   PubMed Web of Science ®Google Scholar
• Matlab (7.10.0). (2010). Natick, MA: The MathWorks.
   Google Scholar
• Mello, J. A., Acharya, S., Fishel, R., & Essigmann, J. M. (1996). The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin. Chemistry and Biology, 3, 579–589.
   PubMed Web of Science ®Google Scholar
• Mills, J. B., & Hagerman, P. J. (2004). Origin of the intrinsic rigidity of DNA. Nucleic Acids Research, 32, 4055–4059.
   PubMed Web of Science ®Google Scholar
• Negureanu, L., & Salsbury, F. R., Jr (2012a). Insights into protein–DNA interactions, stability and allosteric communications: A computational study of MutSα–DNA recognition complexes. Journal of Biomolecular Structure and Dynamics, 29, 757–776.
   PubMed Web of Science ®Google Scholar
• Negureanu, L., & Salsbury, F. R., Jr (2012b). The molecular origin of the MMR-dependent apoptosis pathway from dynamics analysis of MutSα–DNA complexes. Journal of Biomolecular Structure and Dynamics, 30, 347–361.
   PubMed Web of Science ®Google Scholar
• Panigrahi, S. K., & Desiraju, G. R. (2007a). Strong and weak hydrogen bonds in drug–DNA complexes: A statistical analysis. Journal of Biosciences, 32, 677–691.
   PubMed Web of Science ®Google Scholar
• Panigrahi, S. K., & Desiraju, G. R. (2007b). Strong and weak hydrogen bonds in the protein–ligand interface. Proteins, 67, 128–142.
   PubMed Web of Science ®Google Scholar
• Panigrahi, S. K., & Desiraju, G. R. (2008). Strong and weak hydrogen bonds in protein–ligand complexes of kinases: A comparative study. Amino Acids, 34, 617–633.
   PubMed Web of Science ®Google Scholar
• Peltomaki, P. (2003). Role of DNA mismatch repair defects in the pathogenesis of human cancer. Journal of Clinical Oncology, 21, 1174–1179.
   PubMed Web of Science ®Google Scholar
• Rajeswaran, A., Trojan, A., Burnand, B., & Giannelli, M. (2008). Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: a systematic review of randomized controlled trials. Lung Cancer, 59, 1–11.
   PubMed Web of Science ®Google Scholar
• Rosenberg, B., Van Camp, L., & Krigas, T. (1965). Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature, 205, 698–699.
   PubMed Web of Science ®Google Scholar
• Salsbury, F. R., Jr (2010a). Effects of cisplatin binding to DNA on the dynamics of the E. coli MutS Dimer. Protein and Peptide Letters, 17, 744–750.
   PubMed Web of Science ®Google Scholar
• Salsbury, F. R., Jr (2010b). Molecular dynamics simulations of protein dynamics and their relevance to drug discovery. Current Opinion in Phamacology, 10, 738–744.
   PubMed Web of Science ®Google Scholar
• Salsbury, F. R., Jr, Clodfelter, J. E., Gentry, M. B., Hollis, T., & Scarpinato, D. K. (2006). The molecular mechanism of DNA damage recognition by MutS homologs and its consequences for cell death response. Nucleic Acids Research, 34, 2173–2185.
   PubMed Web of Science ®Google Scholar
• Salsbury, F. R., Jr, Crowder, M. W., Kingsmore, S. F., & Huntley, J. J. A. (2009). Molecular dynamics simulations of the metallo-beta-lactamase from Bacteroides fragilis in the presence and absence of a tight-binding inhibitor. Journal of Molecular Modeling, 15, 133–145.
   PubMed Web of Science ®Google Scholar
• Salsbury, F. R., Jr, Crowley, M. F., & Brooks, C. L. (2001). Modeling of the metallo-beta-lactamase from B-fragilis: Structural and dynamic effects of inhibitor binding. Proteins, 44, 448–459.
   PubMed Web of Science ®Google Scholar
• Sarkhel, S., & Desiraju, G. R. (2004). N–HO, O–HO, and C–HO hydrogen bonds in protein–ligand complexes: Strong and weak interactions in molecular recognition. Proteins, 54, 247–259.
   PubMed Web of Science ®Google Scholar
• Scheeff, E. D., Briggs, J. M., & Hawell, S. B. (1999). Molecular modeling of the intrastrand guanine–guanine DNA addcuts produced by cisplatin and oxaliplatin. Molecular Pharmacology, 56, 633–643.
   PubMed Web of Science ®Google Scholar
• Schonlau, M. (2002). The clustergram: A graph for visualizing hierarchical and non-hierarchical cluster analysis. The Stata Journal, 3, 316–327.
   Google Scholar
• Sharma, S., Gong, P., Temple, B., Bhattacharyya, D., Dokholyan, N. V., & Chaney, S. G. (2007). Molecular dynamics simulations of cisplatin- and oxaliplatin-d(GG) intrastrand cross-links reveal differences in their conformational dynamics. Journal of Molecular Biology, 373, 1123–1140.
   PubMed Web of Science ®Google Scholar
• Sharma, R., Graham, J., Blagden, S., & Gabra, H. (2011). Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer. BMC Cancer, 11, 289.
   PubMed Web of Science ®Google Scholar
• Spiegel, K., & Magistrato, A. (2006). Modeling anticancer drug-DNA interactions via mixed QM/MM molecular dynamics simulations. Organic and Biomolecular Chemistry, 4, 2507–2517.
   PubMed Web of Science ®Google Scholar
• Steinbach, P. J., & Brooks, B. R. (1994). New spherical-cutoff methods for long-range forces in macromolecular simulations. Journal of Computational Chemistry, 15, 667–683.
   Web of Science ®Google Scholar
• Straub, J. E., Rashkin, A. B., & Thirumalai, D. (1994). Dynamics in rugged energy landscapes with applications to the S-peptide and ribonuclease. Journal of the American Chemical Society, 116, 2049–2063.
   Web of Science ®Google Scholar
• Takahara, P. M., Rosenzweig, A. C., Frederick, C. A., & Lippard, S. J. (1995). Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin. Nature, 377, 649–652.
   PubMed Web of Science ®Google Scholar
• Taylor, A., & Kennard, O. (1982). Crystallographic evidence for the existence of C–HO, C-HN and C-HCl hydrogen bonds. Journal of the America Chemical Society, 104, 5063–5070.
   Web of Science ®Google Scholar
• Teuben, J. M., Bauer, C., Wang, A. H. J., & Reedijk, J. (1999). Solution structure of a DNA duplex containing a cis-diammineplatinum(II) 1,3-d(GTG) intrastrand cross-link, a major adduct in cells treated with the anticancer drug carboplatin. Biochemistry, 38, 12305–12312.
   PubMed Web of Science ®Google Scholar
• Tiwari, A., & Panigrahi, S. K. (2007). HBAT: A complete package for analyzing strong and weak hydrogen bonds in macromolecular crystal structures. In Silico Biology, 7, 651–661.
   PubMedGoogle Scholar
• Todd, R. C., & Lippard, S. J. (2010). Structure of duplex DNA containing the cisplatin 1,2-Pt(NH3)2–2+-d(GpG) cross-link at 1.77 A resolution. Journal of Inorganic Biochemistry, 104, 902–908.
   PubMed Web of Science ®Google Scholar
• Travers, A. A. (2004). The structural basis for DNA flexibility. The Philosophical Transactions of the Royal Society London, 362, 1423–1438.
   PubMed Web of Science ®Google Scholar
• van Gunsteren, W. F., & Berendsen, H. J. C. (1977). Algorithms for macromolecular dynamics and constraint dynamics. Molecular Physics, 34, 1311–1327.
   Web of Science ®Google Scholar
• Vasilyeva, A., Clodfelter, J. E., Gorczynski, M. J., Gerardi, A. R., King, S. B., Salsbury Jr, F. R., & Scarpinato, K. D. (2010). Parameters of reserpine analogs that induce MSH2/MSH6-dependent cytotoxic response. Journal of Nucleic Acids, Article I D 162018, 13 pages. doi:10.4061/2010/162018.
   Google Scholar
• Vasilyeva, A., Clodfelter, J. E., Reactor, B., Hollis, T., Scarpinato, K. D., & Salsbury, F. R., Jr (2009). Small molecule induction of MSH2-dependent cell death suggests a vital role of mismatch repair proteins in cell death. DNA Repair, 8, 103–113.
   PubMed Web of Science ®Google Scholar
• Wang, D., & Lippard, S. J. (2005). Cellular processing of platinum anticancer drugs. Nature, 4, 307–321.
   Web of Science ®Google Scholar
• Wang, H., Yang, Y., Schofield, M. J., Du, C., Fridman, Y., Lee, S. D., & Erie, D. A. (2003). DNA bending and unbending by MutS govern mismatch recognition and specificity. Proceedings of the National Academy of Sciences USA, 100, 14822–14827.
   PubMed Web of Science ®Google Scholar
• Waozniak, K., & Blasiak, J. (2002). Recognition and repair of DNA–cisplatin adducts. Acta Biochimica Polonica, 49, 583–596.
   PubMed Web of Science ®Google Scholar
• Warren, J. J., Pohlhaus, T. J., Changele, A., Iyer, R. R., Modrich, P. L., & Beese, L. S. (2007). Structure of the human MutS DNA lesion recognition complex. Molecular Cell, 26, 579–592.
   PubMed Web of Science ®Google Scholar
• Wheate, N. J., Walker, S., Craig, G. E., & Onun, R. (2010). The status of platinum anticancer drugs in the clinic and in clinical trials. Dalton Transactions, 39, 813–827.
   Web of Science ®Google Scholar
• Williams, T., & Kelley, C. (2011). Gnuplot 4.5: An interactive plotting program. http://gnuplot.info
   Google Scholar
• Wolfe, K. C., Hastings, W. A., Dutta, S., Long, A., Shapiro, B. A., Woolf, T. B., Guthold, M., & Chirijian, G. S. (2012). Multiscale modeling of double-helical DNA and RNA: A unification through lie groups. Journal Physical Chemistry B,dx.doi.org/10.1021/jp2126015 |.
   Google Scholar
• Wu, Y., Pradhan, P., Havener, J., Boysen, G., Swenberg, J. A., Campbell, S. L., & Chaney, S. G. (2004). NMR solution structure of an oxaliplatin 1,2-d(GG) intrastrand cross-link in a DNA dodecamer duplex. Journal of Molecular Biology, 341, 1251–1269.
   PubMed Web of Science ®Google Scholar
• Yang, W. (2008). Structure and mechanism for DNA lesion recognition. Cell Research, 18, 184–197.
   PubMed Web of Science ®Google Scholar
• Young, L. C., Peters, A. C., Maeda, T., Edelmann, W., Kucherlapati, R., Andrew, S. E., & Tron, V. A. (2003). DNA mismatch repair protein Msh6 is required for optimal levels of ultraviolet-B-induced apoptosis in primary mouse fibroblasts. Journal of Investigative Dermatology, 121, 876–880.
   PubMed Web of Science ®Google Scholar